Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Brian Clark MD

Brian J. Clark MD

Attending Pulmonologist and Critical Care Physician; Assistant Professor of Medicine, Section of Pulmonary Critical Care Medicine, Yale School of Medicine; Yale Center for Asthma and Airway Disease (YCAAD), New Haven, Connecticut

After graduating from residency at Northwestern University in Chicago, IL, Dr. Clark came to New Haven to complete his fellowship in Pulmonary and Critical Care medicine at Yale. After fellowship he has remained at Yale as junior faculty . His chief interest includes the care of severe and difficult to control asthma through the Yale Center for Asthma and Airway Disease. His work in YCAAD involves identification of barriers to optimal asthma care for patients and, when appropriate, application of novel biologic therapies for severe asthma. He also has an interest in pulmonary physiology and cardiopulmonary exercise testing (CPET) as well as teaching pulmonary physiology to fellows. His critical care interests include ventilator management and the heart lung interactions that complicate ICU care.

Disclosures

Dr. Clark is a sub-investigator on asthma trials sponsored by Astra Zeneca, Genentech, and Gossamer. He is the site principal investigator for a pending ICU trial with Lungpacer Medical.

Dr. Clark has never received any salary, honorarium, or payment of any kind from any pharmaceutical or device company.